| P2093 | author name string | Ghigo E | |
| | Grottoli S | |
| | Maccario M | |
| | Camanni F | |
| | Procopio M | |
| | Oleandri SE | |
| | Boffano GM | |
| | Taliano M | |
| P2860 | cites work | The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man | Q69936804 |
| | Inhibition of lipolysis by nicotinic acid and by acipimox | Q71395582 |
| | Effect of arginine on serum levels of insulin and growth hormone in obese subjects | Q72225541 |
| | Interaction of free fatty acids and arginine on growth hormone secretion in man | Q72276262 |
| | Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay | Q76483486 |
| | Hypothalamic modulation of growth hormone secretion in the rhesus monkey: evidence from intracerebroventricular infusions of glucose, free fatty acid, and ketone bodies | Q28333062 |
| | Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. | Q30449288 |
| | Effect of lipids on growth hormone secretion in humans | Q34062745 |
| | Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion | Q34560718 |
| | Insulin suppresses growth hormone secretion by rat pituitary cells | Q34610080 |
| | Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects | Q35809532 |
| | Endocrine function in human obesity | Q40259582 |
| | Cellular mechanism of caprylic acid-induced growth hormone suppression | Q42480578 |
| | Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurones in monolayer culture | Q42497653 |
| | Pituitary response to insulin-induced hypoglycemia in obese subjects before and after fasting | Q43612404 |
| | Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. | Q45127749 |
| | Developmental and sex-related changes of the growth hormone axis in lean and obese Zucker rats | Q45289758 |
| | Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction | Q47233216 |
| | Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity | Q47442906 |
| | Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin | Q48854624 |
| | Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. | Q51633156 |
| | Plasma free fatty acid concentrations in obesity. | Q51692828 |
| | Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. | Q52369747 |
| | Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity | Q60674366 |
| | Effect of the potentiation of cholinergic activity on the variability in individual GH response to GH-releasing hormone | Q60674381 |
| | The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children | Q67486444 |
| | Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men | Q68580010 |
| | Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects | Q68632044 |
| | Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity | Q69178045 |
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 342-346 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity | |
| P478 | volume | 45 | |